These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19239024)
1. [Advances in the study of the microbial efflux pumps and its inhibitors development]. Long QX; Zhou PF; Wu ZH; Wang HH; Xie JP Yao Xue Xue Bao; 2008 Nov; 43(11):1082-8. PubMed ID: 19239024 [TBL] [Abstract][Full Text] [Related]
2. Bacterial efflux systems and efflux pumps inhibitors. Marquez B Biochimie; 2005 Dec; 87(12):1137-47. PubMed ID: 15951096 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of multidrug resistant efflux systems in bacteria. Zechini B; Versace I Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695 [TBL] [Abstract][Full Text] [Related]
4. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance]. Aygül A Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829 [TBL] [Abstract][Full Text] [Related]
5. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria. Spengler G; Kincses A; Gajdács M; Amaral L Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992 [TBL] [Abstract][Full Text] [Related]
6. [Inhibition of pump and permeability mechanisms]. Sánchez P; Alonso A; Martínez JL Rev Esp Quimioter; 1999 Jun; 12(2):116-9. PubMed ID: 10562671 [TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistance efflux pumps - not just for resistance. Piddock LJ Nat Rev Microbiol; 2006 Aug; 4(8):629-36. PubMed ID: 16845433 [TBL] [Abstract][Full Text] [Related]
8. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. Gupta AK; Chauhan DS; Srivastava K; Das R; Batra S; Mittal M; Goswami P; Singhal N; Sharma VD; Venkatesan K; Hasnain SE; Katoch VM J Commun Dis; 2006 Mar; 38(3):246-54. PubMed ID: 17373356 [TBL] [Abstract][Full Text] [Related]
9. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors. Jamshidi S; Sutton JM; Rahman KM Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720 [TBL] [Abstract][Full Text] [Related]
10. [Active efflux as the multidrug resistance mechanism]. Wasaznik A; Grinholc M; Bielawski KP Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193 [TBL] [Abstract][Full Text] [Related]
11. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. Hasdemir U Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic Adjuvants: Make Antibiotics Great Again! Douafer H; Andrieu V; Phanstiel O; Brunel JM J Med Chem; 2019 Oct; 62(19):8665-8681. PubMed ID: 31063379 [TBL] [Abstract][Full Text] [Related]
13. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Sun J; Deng Z; Yan A Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531 [TBL] [Abstract][Full Text] [Related]
14. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance]. Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338 [TBL] [Abstract][Full Text] [Related]
15. Bacterial resistance to antibiotics: active efflux and reduced uptake. Kumar A; Schweizer HP Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells. Amaral L; Spengler G; Martins A; Armada A; Handzlik J; Kiec-Kononowicz K; Molnar J Anticancer Res; 2012 Jul; 32(7):2947-57. PubMed ID: 22753759 [TBL] [Abstract][Full Text] [Related]
17. Multidrug ABC transporters in bacteria. Orelle C; Mathieu K; Jault JM Res Microbiol; 2019; 170(8):381-391. PubMed ID: 31251973 [TBL] [Abstract][Full Text] [Related]
18. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery. Schweizer HP Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of efflux pumps in Gram-negative bacteria. Pagès JM; Masi M; Barbe J Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519 [TBL] [Abstract][Full Text] [Related]
20. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. Lynch AS Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]